Literature DB >> 16379583

Delayed transplantation of human neurons following brain injury in rats: a long-term graft survival and behavior study.

Chen Zhang1, Kathryn E Saatman, Nicolas C Royo, Kristie M Soltesz, Marie Millard, Joost W Schouten, Melissa Motta, Rachel C Hoover, Asenia McMillan, Deborah J Watson, Virginia M-Y Lee, John Q Trojanowski, Tracy K McIntosh.   

Abstract

The NTera2 (NT2) cell line is a homogeneous population of cells, which, when treated in vitro with retinoic acid, terminally differentiate into postmitotic neuronal NT2N cells. Although NT2N neurons transplanted in the acute (24 h postinjury) period survive for up to 1 month following experimental traumatic brain injury (TBI), nothing is known of their ability to survive for longer periods or of their effects when engrafted during the chronic postinjury period. Adult male Sprague-Dawley rats (n = 348; 360-400 g) were initially anesthetized and subjected to severe lateral fluid-percussion (FP) brain injury or sham injury. At 1 month postinjury, only brain-injured animals showing severe neurobehavioral deficits received cryopreserved NT2N neurons stereotaxically transplanted into three sites in the peri-injured cortex (n = 18). Separate groups of similarly brain-injured rats received human fibroblast cells (n = 13) or cell suspension vehicle (n = 14). Sham-injured animals (no brain injury) served as controls and received NT2N transplants (n = 24). All animals received daily immunosuppression for three months. Behavioral testing was performed at 1, 4, 8, and 12 weeks post-transplantation, after which animals were sacrificed for histological analysis. Nissl staining and anti-human neuronal specific enolase (NSE) immunostaining revealed that NT2N neurons transplanted in the chronic post-injury period survived up to 12 weeks post-transplantation, extended processes into the host cortex and immunolabeled positively for synaptophysin. There were no statistical differences in cognitive or motor function among the transplanted brain-injured groups. Long-term graft survival suggests that NT2N neurons may be a viable source of neural cells for transplantation after TBI and also that these grafts can survive for a prolonged time and extend processes into the host cortex when transplanted in the chronic post-injury period following TBI.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16379583     DOI: 10.1089/neu.2005.22.1456

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  12 in total

Review 1.  Concise Review: Human-Animal Neurological Chimeras: Humanized Animals or Human Cells in an Animal?

Authors:  Andrew T Crane; Joseph P Voth; Francis X Shen; Walter C Low
Journal:  Stem Cells       Date:  2019-01-28       Impact factor: 6.277

Review 2.  Cell-based therapy for traumatic brain injury.

Authors:  S Gennai; A Monsel; Q Hao; J Liu; V Gudapati; E L Barbier; J W Lee
Journal:  Br J Anaesth       Date:  2015-08       Impact factor: 9.166

3.  Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?

Authors:  Aileen J Anderson; Daniel L Haus; Mitra J Hooshmand; Harvey Perez; Christopher J Sontag; Brian J Cummings
Journal:  Regen Med       Date:  2011-05       Impact factor: 3.806

4.  The subventricular zone in the immature piglet brain: anatomy and exodus of neuroblasts into white matter after traumatic brain injury.

Authors:  Beth A Costine; Symeon Missios; Sabrina R Taylor; Declan McGuone; Colin M Smith; Carter P Dodge; Brent T Harris; Ann-Christine Duhaime
Journal:  Dev Neurosci       Date:  2015-02-10       Impact factor: 2.984

Review 5.  Cell therapies for traumatic brain injury.

Authors:  Matthew T Harting; James E Baumgartner; Laura L Worth; Linda Ewing-Cobbs; Adrian P Gee; Mary-Clare Day; Charles S Cox
Journal:  Neurosurg Focus       Date:  2008       Impact factor: 4.047

6.  Antibodies directed to the gram-negative bacterium Neisseria gonorrhoeae cross-react with the 60 kDa heat shock protein and lead to impaired neurite outgrowth in NTera2/D1 cells.

Authors:  B Reuss; A R Asif
Journal:  J Mol Neurosci       Date:  2014-02-28       Impact factor: 3.444

7.  Subacute neural stem cell therapy for traumatic brain injury.

Authors:  Matthew T Harting; Leeann E Sloan; Fernando Jimenez; James Baumgartner; Charles S Cox
Journal:  J Surg Res       Date:  2008-04-23       Impact factor: 2.192

Review 8.  New perspectives on central and peripheral immune responses to acute traumatic brain injury.

Authors:  Mahasweta Das; Subhra Mohapatra; Shyam S Mohapatra
Journal:  J Neuroinflammation       Date:  2012-10-12       Impact factor: 8.322

Review 9.  Optimizing the success of cell transplantation therapy for stroke.

Authors:  Tonya M Bliss; Robert H Andres; Gary K Steinberg
Journal:  Neurobiol Dis       Date:  2009-10-12       Impact factor: 7.046

Review 10.  Pre- and postmortem imaging of transplanted cells.

Authors:  Anna Andrzejewska; Adam Nowakowski; Miroslaw Janowski; Jeff W M Bulte; Assaf A Gilad; Piotr Walczak; Barbara Lukomska
Journal:  Int J Nanomedicine       Date:  2015-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.